Your Article Summary
See Latest ArticlesA practical approach to using ciclosporin
Dermatology in Practice, 07/01/09
Ciclosporin is an immunosuppressant drug used in dermatology to treat patients with severe or recalcitrant psoriasis, or with severe atopic eczema. It has important adverse effects, particularly on the kidneys, so careful counselling and monitoring are required.
Related Articles
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia
British Journal of Haematology, 10/16/09
Relevance Score: 84%
Limited Sampling Models and Bayesian Estimation for Mycophenolic Acid Area under the Curve Prediction in Stable Renal Transplant Patients Co-Medicated with Ciclosporin or Sirolimus
Clinical Pharmacokinetics, 10/15/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows
European Journal of Dermatology, 11/30/09
An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo
European Journal of Dermatology, 11/30/09
Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne
International Journal of Women's Health, 11/30/09
Today in Derm Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Cutaneous acanthamebiasis infection in immunocompetent and immunocompromised patients
International Journal of Dermatology, 11/30/09
Comparison between PAS and GMS stains for the diagnosis of onychomycosis
Journal of Cutaneous Pathology, 11/30/09
Leg ulcer caused by Mycobacterium ulcerans ssp. shinshuense infection
International Journal of Dermatology, 11/30/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
The DESIRE study – psoriasis patients’ satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice
European Journal of Dermatology, 11/30/09
Lack of association between angiotensin I-converting enzyme insertiondeletion polymorphism and psoriasis or psoriatic arthritis in Spain
International Journal of Dermatology, 11/30/09
Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis
International Journal of Dermatology, 11/25/09